321 related articles for article (PubMed ID: 9191525)
21. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
22. [Flow cytometric analysis of DNA from 98 cases of soft tissue tumors and its clinical significance].
Li S
Zhonghua Wai Ke Za Zhi; 1990 May; 28(5):281-4, 318. PubMed ID: 2086097
[TBL] [Abstract][Full Text] [Related]
23. The clinical value of flow cytometric DNA content analysis in patients with soft tissue sarcomas.
Samur M; Pamir A; Akbulut H; Erekul S; Sağlik Y; Yildiz Y; Dinçol D; Içli F
Sarcoma; 1999; 3(3-4):171-5. PubMed ID: 18521281
[TBL] [Abstract][Full Text] [Related]
24. Primary sarcomas of the kidney. A clinicopathologic and DNA flow cytometric study of 17 cases.
Grignon DJ; Ayala AG; Ro JY; el-Naggar A; Papadopoulos NJ
Cancer; 1990 Apr; 65(7):1611-8. PubMed ID: 2155701
[TBL] [Abstract][Full Text] [Related]
25. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma.
Sampedro A; Salas-Bustamante A; López-Artimez M; García-Muñíz JL; Urdiales G
Anal Quant Cytol Histol; 1999 Aug; 21(4):347-52. PubMed ID: 10560513
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric S-phase fraction in soft-tissue sarcoma: prognostic importance analysed in 160 patients.
Gustafson P; Fernö M; Akerman M; Baldetorp B; Willén H; Killander D; Rydholm A
Br J Cancer; 1997; 75(1):94-100. PubMed ID: 9000604
[TBL] [Abstract][Full Text] [Related]
27. DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters.
Redkar AA; Balsara BR; Bhisey AN; Sampat MB; Mittra I
Indian J Med Res; 1992 Aug; 96():223-9. PubMed ID: 1428060
[TBL] [Abstract][Full Text] [Related]
28. DNA flow analysis of soft tissue tumors.
Kreicbergs A; Tribukait B; Willems J; Bauer HC
Cancer; 1987 Jan; 59(1):128-33. PubMed ID: 3024798
[TBL] [Abstract][Full Text] [Related]
29. Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.
Rudolph P; Kellner U; Chassevent A; Collin F; Bonichon F; Parwaresch R; Coindre JM
Am J Pathol; 1997 Jun; 150(6):1997-2007. PubMed ID: 9176393
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
31. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
[TBL] [Abstract][Full Text] [Related]
32. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers.
Ohyama S; Yonemura Y; Miyazaki I
Cancer; 1990 Jan; 65(1):116-21. PubMed ID: 2293858
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric DNA analysis and lysosomal cathepsins B and L in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance.
Russo A; Bazan V; Gebbia N; Pizzolanti G; Tumminello FM; Dardanoni G; Ingria F; Restivo S; Tomasino RM; Leto G
Cancer; 1995 Nov; 76(10):1757-64. PubMed ID: 8625044
[TBL] [Abstract][Full Text] [Related]
35. DNA ploidy and proliferative activity (S-phase) in childhood soft-tissue sarcomas: their value as prognostic indicators.
Niggli FK; Powell JE; Parkes SE; Ward K; Raafat F; Mann JR; Stevens MC
Br J Cancer; 1994 Jun; 69(6):1106-10. PubMed ID: 8198978
[TBL] [Abstract][Full Text] [Related]
36. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
37. DNA content in juvenile granulosa cell tumors of the ovary: a study of early- and advanced-stage disease.
Jacoby AF; Young RH; Colvin RB; Flotte TJ; Preffer F; Scully RE; Swymer CM; Bell DA
Gynecol Oncol; 1992 Jul; 46(1):97-103. PubMed ID: 1634146
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
[TBL] [Abstract][Full Text] [Related]
39. DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implications.
Tinari N; Natoli C; Angelucci D; Tenaglia R; Fiorentino B; Di Stefano P; Amatetti C; Zezza A; Nicolai M; Iacobelli S
Cancer; 1993 Feb; 71(4):1289-96. PubMed ID: 8435806
[TBL] [Abstract][Full Text] [Related]
40. DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast.
Frost AR; Karcher DS; Terahata S; Siegel RS; Silverberg SG
Mod Pathol; 1996 Sep; 9(9):930-7. PubMed ID: 8878026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
